CNS Pharmaceuticals, Inc.

About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals is a biotechnology company focused on transforming oncology through pioneering research and transformative therapies, primarily targeting glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer, to improve patient outcomes.

Products & Services

Berubicin:The first anthracycline to cross the blood-brain barrier, developed for the treatment of brain malignancies.

TPI 287:A late-stage, novel, blood-brain barrier permeable taxane for treating brain tumors.

Specialties

Glioblastoma Multiforme (GBM) Treatment Primary Central Nervous System Lymphoma Brain Malignancies Research Blood-Brain Barrier Permeable Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 5000000 MR: - FA: $5M FAN: 5000000	D: 2025-05-13 FD: 2025-05-13	-
2	RT: Private Placement T: - FT: Private Placement	A: 5220000 MR: - FA: 5.22M shares of common stock and warrants FAN: 5220000	D: 2025-04-14 FD: 2025-04-14	-
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 3000000 MR: - FA: $3 million FAN: 3000000	D: 2024-10-23 FD: 2024-10-23	1 investors
4	RT: Registered Direct Offering and Concurrent Private Placement T: - FT: Registered Direct Offering and Concurrent Private Placement	A: 1980000 MR: - FA: approximately $1.98 million FAN: 1980000	D: 2024-07-03 FD: 2024-07-03	1 investors
5	RT: Registered Direct Offering and Concurrent Private Placement T: - FT: Registered Direct Offering and Concurrent Private Placement	A: 1390000 MR: - FA: approximately $1.39 million FAN: 1390000	D: 2024-06-26 FD: 2024-06-26	1 investors
6	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 1370000 MR: - FA: approximately $1.37 million FAN: 1370000	D: 2024-06-14 FD: 2024-06-14	1 investors
7	RT: Public Offering T: - FT: Public Offering	A: 4000000 MR: - FA: $4.0 Million FAN: 4000000	D: 2024-01-29 FD: 2024-01-29	2 investors
8	RT: Public Offering T: - FT: Public Offering	A: 6000000 MR: - FA: $6 million FAN: 6000000	D: 2022-12-05 FD: 2022-12-05	-
9	RT: Public Offering T: - FT: Public Offering	A: 6000000 MR: - FA: $6.0 Million FAN: 6000000	D: 2022-11-30 FD: 2022-11-30	-
10	RT: Private Placement T: - FT: Private Placement	A: 11500000 MR: - FA: 11.5 million FAN: 11500000	D: 2022-01-25 FD: 2022-01-25	-
11	RT: Private Placement T: - FT: Private Placement	A: 11500000 MR: - FA: $11.5 million FAN: 11500000	D: 2022-01-11 FD: 2022-01-11	-
12	RT: Private Placement T: - FT: Private Placement	A: 11500000 MR: - FA: 11.5 million FAN: 11500000	D: 2022-01-10 FD: 2022-01-10	-
13	RT: Private Placement T: - FT: Private Placement	A: 11500000 MR: - FA: 11.5 million FAN: 11500000	D: 2022-01-06 FD: 2022-01-06	1 investors
14	RT: Public Offering T: - FT: Public Offering	A: 10000000 MR: - FA: 10,000,000 FAN: 10000000	D: 2021-01-04 FD: 2021-01-04	-
15	RT: Public Offering T: - FT: Public Offering	A: 10000000 MR: - FA: $10,000,000 FAN: 10000000	D: 2020-12-23 FD: 2020-12-23	1 investors
16	RT: Grant T: - FT: Grant	A: 5798875 MR: - FA: $5,798,875 FAN: 5798875	D: 2019-12-11 FD: 2019-12-11	1 investors
17	RT: IPO Over-Allotment T: - FT: IPO Over-Allotment	A: 1300000 MR: - FA: $1.3 million FAN: 1300000	D: 2019-11-21 FD: 2019-11-21	1 investors
18	RT: IPO T: - FT: IPO	A: 8500000 MR: - FA: 8.5 million FAN: 8500000	D: 2019-11-13 FD: 2019-11-13	1 investors

Public Offering Latest

2025-05-13

$5.0M

Private Placement 2025-04-14

$5.2M

Registered Direct Offering 2024-10-23

$3.0M

View 17 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Climaco

Chief Executive Officer

C

Chris Downs

Chief Financial Officer

D

Don Picker

Chief Scientific Officer

S

Sandra Silberman

Chief Medical Officer

Z

Zena Muzyczenko

Vice President of Clinical Operations

F

Faith Charles

Chair

View 10 more team members with Pro

Unlock Full Team Directory

Recent News